Madison Avenue Partners, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") (OVID)

Filing Manager: Madison Avenue Partners, LP
Reporting Manager: Madison Avenue Partners, LP
Security: Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock")
Symbol: OVID
Shares outstanding: 71.3M shares
Disclosed Ownership: 2.85M shares
Ownership: 4%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:41:31 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (6)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Madison Avenue Partners, LP	4%	2.85M	2.85M	/s/ Eli Samaha	Eli Samaha, as Managing Member of EMAI Management, LLC the General Partner of Madison Avenue Partners, LP
Madison Avenue International LP	4%	2.85M	2.85M	/s/ Eli Samaha	Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
EMAI Management, LLC	4%	2.85M	2.85M	/s/ Eli Samaha	Eli Samaha, as Managing Member
Madison Avenue GP, LLC	4%	2.85M	2.85M	/s/ Eli Samaha	Eli Samaha, as Manager
Caraway Jackson Investments LLC	4%	2.85M	2.85M	/s/ Eli Samaha	Eli Samaha, as Member
Eli Samaha	4%	2.85M	2.85M	/s/ Eli Samaha	Eli Samaha